HMGB1 and myelosuppression: Collectively, our data demonstrated that AS and SRP alleviated CTX-induced cell injury in BMHSCs via up-regulation of HMGB1 through inhibition of miR-142-3p, improved the hematopoietic function, and cured myelosuppression in CTX-induced myelosuppression mice.